Eric Schlumpf active positions
| Companies | Position | Start | End |
|---|---|---|---|
Stuart Therapeutics LLC
 Stuart Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Stuart Therapeutics LLC, founded in 2017, is a company based in Stuart, FL that specializes in the development of ECM-targeting therapeutics for disease treatment. Stuart Therapeutics has conducted extensive research in a variety of anterior and posterior segment ophthalmic disease indications, demonstrating rapid effects in treated tissues. The company's patented platform technology, PolyCol™, is a portfolio of synthesized collagen mimetic peptides designed to repair disease or injury-damaged helical collagen structures. This repair results in a restoration of homeostatic cell signaling, positively affecting cell growth and proliferation while reducing inflammation. The company was founded in 2018 by Eric Schlumpf, who has been the CEO since then. | Director/Board Member | 31/12/2017 | - |
| Chief Executive Officer | 31/12/2017 | - | |
| Founder | 31/12/2017 | - | |
| President | 31/12/2017 | - |
Career history of Eric Schlumpf
Statistics
International
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Stuart Therapeutics LLC
Stuart Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Stuart Therapeutics LLC, founded in 2017, is a company based in Stuart, FL that specializes in the development of ECM-targeting therapeutics for disease treatment. Stuart Therapeutics has conducted extensive research in a variety of anterior and posterior segment ophthalmic disease indications, demonstrating rapid effects in treated tissues. The company's patented platform technology, PolyCol™, is a portfolio of synthesized collagen mimetic peptides designed to repair disease or injury-damaged helical collagen structures. This repair results in a restoration of homeostatic cell signaling, positively affecting cell growth and proliferation while reducing inflammation. The company was founded in 2018 by Eric Schlumpf, who has been the CEO since then. | Commercial Services |
- Stock Market
- Insiders
- Eric Schlumpf
- Experience
